An exploratory analysis of the dutch pharmaceutical supply chain

The outbreak of the COVID-19 pandemic challenged the Dutch pharmaceutical supply chain (PSC) and required tremendous creativity and effort from PSC partners to guarantee the availability of drugs in the Netherlands and, consequently, Dutch patients’ well-being. At the same time, the COVID-19 pandemic exposed and compounded existing issues and vulnerabilities in the Dutch PSC. This report presents an exploratory analysis of the structure of the Dutch PSC. Insights were gathered from the literature and a series of interviews were conducted with key PSC actors in the Netherlands. We identify the... Mehr ...